NCT07479992 Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram Study
| NCT ID | NCT07479992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Idoven 1903 S.L. |
| Condition | Aortic Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-04-28 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-04-28 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
AoS-SEDAI study is an observational, multicenter, retrospective and prospective clinical study. This study aims to assess Willem Artificial Intelligence (AI) ability to distinguish between aortic stenosis (AS) and non-AS patients from 12-lead electrocardiogram (ECG) data.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * All available 12-lead ECG with a 10 seconds minimum length on raw data digital format will be included * Available clinical data corresponding to each ECG to confirm patient demographics and Aortic Stenosis diagnosis * Available transthoracic echocardiogram (TTE) within +/- 90 days of each ECG recording No exclusion criteria are defined for this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07479992 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07479992 currently recruiting?
Yes, NCT07479992 is actively recruiting participants. Contact the research team at clinical@idoven.ai for enrollment information.
Where is the NCT07479992 trial being conducted?
This trial is being conducted at Bonn, Germany, Munich, Germany.
Who is sponsoring the NCT07479992 clinical trial?
NCT07479992 is sponsored by Idoven 1903 S.L.. The trial plans to enroll 5,000 participants.